About this trial
This prospective case series aims to evaluate the clinical and radiographic outcomes of immediate implant placement using the socket shield technique combined with concentrated growth factors (CGF) and xenograft in the esthetic zone. The study will assess crestal bone level changes and implant stability over a 6-month follow-up period.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years old. (Younis, W., & El-Rashidy, A. 2020).
Both male and female patients.
Maxillary, anterior and premolar segments.
Disqualifiers
A medical history that contraindicates oral surgical treatment such as (uncontrolled/untreated diabetes mellitus, immuno-compromised status, radio or chemotherapy of the oral and maxillofacial region, treatment with oral and/or intravenous bisphosphonates).
Presence of active or untreated periodontal disease.
Vertical root fractures involving the buccal aspect.
Tooth /teeth with horizontal fractures below bone level.
Trial design
Single group
Treatments tested in this trial
Socket Shield Technique with Immediate Implant Placement and CGF + Xenograft
Procedure/SurgeryThe procedure involves partial extraction therapy using the socket shield technique, where the buccal portion of the root is preserved to maintain the alveolar bone. Immediate implant placement is performed into the extraction socket. Concentrated growth factors (CGF) are prepared from the patient's autologous blood via centrifugation and combined with xenograft to form a "sticky bone" graft. This graft is placed in the jumping gap between the implant and socket wall to enhance bone regeneration and healing. Implant stability will be measured using resonance frequency analysis (Osstell), and radiographic evaluation will be performed using CBCT.
Treatment groups
Trial outcomes
Primary outcomes
crestal bone level
Evaluation of changes in crestal bone level around the dental implant using cone-beam computed tomography (CBCT). Measurements will be taken from a fixed reference point on the implant to the first bone-to-implant contact recorded in millimeters (mm)
Secondary outcomes
Implant Stability (ISQ Values)
Implant stability will be assessed using resonance frequency analysis with the Osstell device and recorded as Implant Stability Quotient (ISQ). ISQ values range from 1 to 100, where higher values indicate greater implant stability and a better outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: